Target intelligence / Profile preview

Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25)

Target
SNAP-25
Molecular classification
SNARE protein, t-SNARE, Membrane-associated protein
01

Overview

Synaptosomal-associated protein 25 (SNAP-25) is a critical component of the SNARE (Soluble NSF Attachment Protein Receptor) complex, which mediates the fusion of synaptic vesicles with the presynaptic plasma membrane. Located primarily on the cytosolic face of the plasma membrane in nerve terminals, SNAP-25 contributes two alpha-helices to the four-helix bundle of the SNARE complex, working alongside syntaxin-1 and synaptobrevin-2 to facilitate calcium-triggered neurotransmitter exocytosis (UniProt P60880). In cholinergic presynaptic terminals, SNAP-25 is the specific molecular target of Botulinum neurotoxin type A (BoNT/A). The toxin enters the neuron and its light chain proteolytically cleaves SNAP-25 near the C-terminus, rendering it unable to form a functional SNARE complex (StatPearls, Botulinum Toxin). This action effectively blocks the release of acetylcholine into the neuromuscular junction, leading to localized muscle paralysis. This mechanism is widely utilized in clinical practice to treat conditions such as cervical dystonia, blepharospasm, chronic migraine, and various forms of muscle spasticity (PubMed PMC3022451). Beyond its role in the peripheral nervous system, SNAP-25 is also essential for central neurotransmission, and its dysfunction or genetic variation has been linked to neuropsychiatric and neurodevelopmental disorders including schizophrenia and ADHD (PubMed PMC2824144).

Other names
SNAP25Synaptosomal-associated 25 kDa proteinSuperproteinSUPRIC-4
02

Mechanism of action

Proteolytic cleavage of SNAP-25 by the light chain of Botulinum neurotoxin type A, which prevents the formation of the SNARE complex and inhibits the release of acetylcholine.

03

Biological functions

Vesicle docking and fusionNeurotransmitter releaseExocytosisSynaptic plasticityRegulation of voltage-gated calcium channels
04

Disease associations

Muscle spasticityDystoniaChronic migraineHyperhidrosisOveractive bladderSchizophreniaAttention deficit hyperactivity disorder (ADHD)Epilepsy
05

Safety considerations

Distant spread of toxin effect (botulism)Muscle weaknessRespiratory failureDysphagiaImmunogenicity (formation of neutralizing antibodies)
06

Interacting drugs

OnabotulinumtoxinA

5 more in the full profile.

07

Biomarkers

Cleaved SNAP-25 (cSNAP-25)SNAP-25 levels in cerebrospinal fluid

Beyond the preview

Go deeper on Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synaptosomal-associated protein 25 (SNAP-25) (SNAP-25).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call